Position in RIGL
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$238,827
-$78,329 QoQ
Shares Held
6,105
-17.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#95
of 156 holders
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $29,990,834 across 34 Biotechnology names. RIGL ranks #21 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,721 | $16,750,232 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
8,663 | $2,087,523 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,437 | $1,519,566 | |
| 4 | ARGX |
Argenx SE
|
1,543 | $1,431,549 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
44,542 | $755,877 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
3,115 | $583,377 | |
| 7 | MRNA |
Moderna, Inc.
|
7,765 | $543,782 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
3,712 | $455,016 |
All Filings in RIGL
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,827 | 6,105 | Shares | Sole | 2026-07-27 | |
| 2025-12-31 | $317,156 | 7,405 | Shares | Sole | 2026-01-28 | |
| No filing history on record for this holder in this stock. | ||||||